Advanced search
Publication Cover
Expert Review of Cardiovascular Therapy Volume 11, 2013 - Issue 9
Submit an article Journal homepage
221
Views
6
CrossRef citations to date
0
Altmetric
Clinical Trial Report

A review of apixaban for stroke prevention in atrial fibrillation: insights from ARISTOTLE

Connie N HessCorrespondence[email protected]
,
Sana M Al-Khatib Duke Clinical Research Institute, Durham, NC, USA
,
Christopher B Granger Duke Clinical Research Institute, Durham, NC, USA
&
Renato Lopes Duke Clinical Research Institute, Durham, NC, USA
Pages 1105-1114 | Published online: 10 Jan 2014

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Julia Seeger & Jochen Wöhrle. (2020) Apixaban: An Update of the Evidence for Its Place in the Prevention of Stroke in Patients with Atrial Fibrillation. Core Evidence 15, pages 1-6.
Read now

Articles from other publishers (5)

Benjamin E. Peterson & Deepak L. Bhatt. (2018) Management of Anticoagulation in Patients with Atrial Fibrillation Undergoing PCI: Double or Triple Therapy?. Current Cardiology Reports 20:11.
Crossref
Souad Moudallel, Stephane Steurbaut, Pieter Cornu & Alain Dupont. (2018) Appropriateness of DOAC Prescribing Before and During Hospital Admission and Analysis of Determinants for Inappropriate Prescribing. Frontiers in Pharmacology 9.
Crossref
Benjamin E. Peterson, Sana M. Al-Khatib & Christopher B. Granger. (2016) Apixaban to prevent stroke in patients with atrial fibrillation: a review. Therapeutic Advances in Cardiovascular Disease 11:3, pages 91-104.
Crossref
Amitava Banerjee & Thomas Pogge. (2014) The Health Impact Fund: How Might It Work for Novel Anticoagulants in Atrial Fibrillation?. Global Heart 9:2, pages 255.
Crossref
Meena P. Rao, Sean D. Pokorney & Christopher B. Granger. (2014) Atrial Fibrillation: A Review of Recent Studies with a Focus on Those from the Duke Clinical Research Institute. Scientifica 2014, pages 1-11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.